EE200300396A - Epotilooni derivaatide kasutamine refraktaarsete kasvajate raviks - Google Patents
Epotilooni derivaatide kasutamine refraktaarsete kasvajate raviksInfo
- Publication number
- EE200300396A EE200300396A EEP200300396A EEP200300396A EE200300396A EE 200300396 A EE200300396 A EE 200300396A EE P200300396 A EEP200300396 A EE P200300396A EE P200300396 A EEP200300396 A EE P200300396A EE 200300396 A EE200300396 A EE 200300396A
- Authority
- EE
- Estonia
- Prior art keywords
- treatment
- epothilone derivatives
- refractory tumors
- tumors
- refractory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26983601P | 2001-02-20 | 2001-02-20 | |
PCT/US2002/004255 WO2002066038A1 (en) | 2001-02-20 | 2002-02-06 | Treatment of refractory tumors using epothilone derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200300396A true EE200300396A (et) | 2003-12-15 |
Family
ID=23028846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200300396A EE200300396A (et) | 2001-02-20 | 2002-02-06 | Epotilooni derivaatide kasutamine refraktaarsete kasvajate raviks |
Country Status (18)
Country | Link |
---|---|
US (2) | US6686380B2 (et) |
EP (1) | EP1385529A4 (et) |
JP (1) | JP2004522774A (et) |
KR (1) | KR20040025895A (et) |
CN (1) | CN1774253A (et) |
BG (1) | BG108075A (et) |
BR (1) | BR0207487A (et) |
CA (1) | CA2438610A1 (et) |
EE (1) | EE200300396A (et) |
HU (1) | HUP0303175A2 (et) |
IL (1) | IL156988A0 (et) |
IS (1) | IS6918A (et) |
MX (1) | MXPA03007394A (et) |
NO (1) | NO20033684L (et) |
PL (1) | PL363362A1 (et) |
RU (1) | RU2003128311A (et) |
WO (1) | WO2002066038A1 (et) |
ZA (1) | ZA200306173B (et) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050043376A1 (en) * | 1996-12-03 | 2005-02-24 | Danishefsky Samuel J. | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
AU756699B2 (en) | 1996-12-03 | 2003-01-23 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
US6204388B1 (en) * | 1996-12-03 | 2001-03-20 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
US6605599B1 (en) | 1997-07-08 | 2003-08-12 | Bristol-Myers Squibb Company | Epothilone derivatives |
US6780620B1 (en) * | 1998-12-23 | 2004-08-24 | Bristol-Myers Squibb Company | Microbial transformation method for the preparation of an epothilone |
US20020058286A1 (en) * | 1999-02-24 | 2002-05-16 | Danishefsky Samuel J. | Synthesis of epothilones, intermediates thereto and analogues thereof |
WO2002062338A1 (en) | 2001-01-25 | 2002-08-15 | Bristol-Myers Squibb Company | Parenteral formulation containing epothilone analogs |
BRPI0207961B8 (pt) * | 2001-03-14 | 2021-05-25 | Bristol Myers Squibb Co | uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos. |
TW200403994A (en) * | 2002-04-04 | 2004-03-16 | Bristol Myers Squibb Co | Oral administration of EPOTHILONES |
TW200400191A (en) * | 2002-05-15 | 2004-01-01 | Bristol Myers Squibb Co | Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives |
US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
EP2186811A1 (en) | 2002-08-23 | 2010-05-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
US6921769B2 (en) | 2002-08-23 | 2005-07-26 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
US7091193B2 (en) | 2002-10-09 | 2006-08-15 | Kosan Biosciences Incorporated | Therapeutic formulations |
TW200503738A (en) * | 2003-07-16 | 2005-02-01 | Tzu Chi Buddhist General Hospital | Method for extracting antineoplastic components from bupleurum scorzonerifolium |
US20050171167A1 (en) * | 2003-11-04 | 2005-08-04 | Haby Thomas A. | Process and formulation containing epothilones and analogs thereof |
US20090004277A1 (en) * | 2004-05-18 | 2009-01-01 | Franchini Miriam K | Nanoparticle dispersion containing lactam compound |
WO2006017761A2 (en) * | 2004-08-05 | 2006-02-16 | Emory University | Epothilone analogues as therapeutic agents |
AR052142A1 (es) | 2004-11-18 | 2007-03-07 | Bristol Myers Squibb Co | Perla recubierta enterica que comprende ixabepilona, y preparacion y administracion de la misma |
US20060134214A1 (en) * | 2004-11-18 | 2006-06-22 | Ismat Ullah | Enteric coated bead comprising epothilone or epothilone analog, and preparation and administration thereof |
EP2634252B1 (en) | 2005-02-11 | 2018-12-19 | University of Southern California | Method of expressing proteins with disulfide bridges |
WO2007130501A2 (en) | 2006-05-01 | 2007-11-15 | University Of Southern California | Combination therapy for treatment of cancer |
US8463852B2 (en) * | 2006-10-06 | 2013-06-11 | Oracle International Corporation | Groupware portlets for integrating a portal with groupware systems |
WO2010056901A2 (en) | 2008-11-13 | 2010-05-20 | University Of Southern California | Method of expressing proteins with disulfide bridges with enhanced yields and activity |
CA2799202C (en) | 2010-05-18 | 2016-07-05 | Cerulean Pharma Inc. | Compositions and methods for treatment of autoimmune and other diseases |
US11478505B2 (en) | 2020-01-10 | 2022-10-25 | R-Pharm Us Operating Llc | Compositions of ixabepilone |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4138042C2 (de) | 1991-11-19 | 1993-10-14 | Biotechnolog Forschung Gmbh | Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel |
WO1996006604A2 (en) * | 1994-08-31 | 1996-03-07 | Eli Lilly And Company | Methods for identifying and treating resistant tumors |
DE19542986A1 (de) | 1995-11-17 | 1997-05-22 | Biotechnolog Forschung Gmbh | Epothilon-Derivate und deren Verwendung |
DE19639456A1 (de) | 1996-09-25 | 1998-03-26 | Biotechnolog Forschung Gmbh | Epothilon-Derivate, Herstellung und Mittel |
EP1440973A3 (de) | 1995-11-17 | 2004-10-20 | Gesellschaft für biotechnologische Forschung mbH (GBF) | Epothilonderivate, Herstellung und Mittel |
DE19636343C1 (de) | 1996-08-30 | 1997-10-23 | Schering Ag | Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B |
DE19645362A1 (de) | 1996-10-28 | 1998-04-30 | Ciba Geigy Ag | Verfahren zur Herstellung von Epothilon A und B und Derivaten |
NZ334821A (en) | 1996-08-30 | 2000-12-22 | Novartis Ag | Method for producing epothilones |
US5969145A (en) | 1996-08-30 | 1999-10-19 | Novartis Ag | Process for the production of epothilones and intermediate products within the process |
DE19645361A1 (de) | 1996-08-30 | 1998-04-30 | Ciba Geigy Ag | Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B, Teil II |
WO1998022461A1 (de) | 1996-11-18 | 1998-05-28 | GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) | Epothilone c, d, e und f, deren herstellung und deren verwendung als cytostatische mittel bzw. als pflanzenschutzmittel |
US6515016B2 (en) | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
US6867305B2 (en) | 1996-12-03 | 2005-03-15 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
AU756699B2 (en) * | 1996-12-03 | 2003-01-23 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
US6204388B1 (en) | 1996-12-03 | 2001-03-20 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
US6441186B1 (en) | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
US6380394B1 (en) | 1996-12-13 | 2002-04-30 | The Scripps Research Institute | Epothilone analogs |
DE19701758A1 (de) | 1997-01-20 | 1998-07-23 | Wessjohann Ludgar A Dr | Epothilone-Synthesebausteine |
CN1544436A (zh) | 1997-02-25 | 2004-11-10 | ���\���о�����˾��GBF�� | 3,7-保护的环氧噻嗪酮-n-氧化物及其制备方法 |
ATE224316T1 (de) | 1997-03-06 | 2002-10-15 | Harry Nijenhuis Man B V | Umschlageinrichtung für container und ein eisenbahnwagen |
DE19713970B4 (de) | 1997-04-04 | 2006-08-31 | R&D-Biopharmaceuticals Gmbh | Epothilone-Synthesebausteine II - Prenylderivate |
JP4065573B2 (ja) | 1997-04-18 | 2008-03-26 | ベーリンガー・インゲルハイム・インテルナツィオナール・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 反応媒体として圧縮二酸化炭素中における二官能性または多官能性基質の選択的オレフィンメタセシス |
DE19720312A1 (de) | 1997-05-15 | 1998-11-19 | Hoechst Ag | Zubereitung mit erhöhter in vivo Verträglichkeit |
DE19821954A1 (de) | 1997-05-15 | 1998-11-19 | Biotechnolog Forschung Gmbh | Verfahren zur Herstellung eines Epothilon-Derivats |
DE19726627A1 (de) | 1997-06-17 | 1998-12-24 | Schering Ag | Zwischenprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Epothilon |
US6605599B1 (en) | 1997-07-08 | 2003-08-12 | Bristol-Myers Squibb Company | Epothilone derivatives |
ATE224882T1 (de) | 1997-07-16 | 2002-10-15 | Schering Ag | Thiazolderivate, verfahren zur herstellung und verwendung |
CA2299608A1 (en) | 1997-08-09 | 1999-02-18 | Schering Aktiengesellschaft | New epothilone derivatives, method for producing same and their pharmaceutical use |
US6982142B2 (en) * | 1997-12-01 | 2006-01-03 | John Wayne Cancer Institute | Methods for screening therapeutically effective agents |
US6365749B1 (en) | 1997-12-04 | 2002-04-02 | Bristol-Myers Squibb Company | Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
SK287487B6 (sk) | 1998-02-05 | 2010-11-08 | Novartis Ag | Lyofilizovaná kompozícia a rekonštituovaná lyofilizovaná kompozícia |
US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
FR2775187B1 (fr) * | 1998-02-25 | 2003-02-21 | Novartis Ag | Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo |
IL138113A0 (en) | 1998-02-25 | 2001-10-31 | Sloan Kettering Inst Cancer | Synthesis of epothilones, intermediates thereto and analogues thereof |
US6302838B1 (en) * | 1998-02-25 | 2001-10-16 | Novartis Ag | Cancer treatment with epothilones |
US6380395B1 (en) | 1998-04-21 | 2002-04-30 | Bristol-Myers Squibb Company | 12, 13-cyclopropane epothilone derivatives |
AU5036999A (en) | 1998-06-30 | 2000-01-17 | Schering Aktiengesellschaft | Epothilon derivatives, their preparation process, intermediate products and their pharmaceutical use |
IL143069A0 (en) | 1998-11-20 | 2002-04-21 | Kosan Biosciences Inc | Recombinant methods and materials for producing epothilone and epothilone derivatives |
CA2352505C (en) | 1998-12-22 | 2009-04-07 | Novartis Ag | Epothilone derivatives and their use as antitumor agents |
PL349863A1 (en) | 1999-02-18 | 2002-09-23 | Schering Ag | 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use |
BR0008379A (pt) | 1999-02-22 | 2002-09-24 | Biotechnolog Forschung Gmbh | Epotilonas modificadas em c-21 |
US6211412B1 (en) | 1999-03-29 | 2001-04-03 | The University Of Kansas | Synthesis of epothilones |
PE20010116A1 (es) | 1999-04-30 | 2001-02-15 | Schering Ag | Derivados de 6-alquenil-, 6-alquinil- y 6-epoxi-epotilona, procedimientos para su preparacion |
FR2793288B1 (fr) | 1999-05-06 | 2001-07-20 | Transrol | Rotule permettant la transmission d'un couple |
US6518421B1 (en) | 2000-03-20 | 2003-02-11 | Bristol-Myers Squibb Company | Process for the preparation of epothilone analogs |
US6593115B2 (en) | 2000-03-24 | 2003-07-15 | Bristol-Myers Squibb Co. | Preparation of epothilone intermediates |
UA75365C2 (en) | 2000-08-16 | 2006-04-17 | Bristol Myers Squibb Co | Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon |
EP1353668B1 (en) | 2001-01-25 | 2008-03-19 | Bristol-Myers Squibb Company | Processes for the preparation of pharmaceutical preparations containing epothilone analogues for the treatment of cancer |
WO2002062338A1 (en) | 2001-01-25 | 2002-08-15 | Bristol-Myers Squibb Company | Parenteral formulation containing epothilone analogs |
WO2002058699A1 (en) | 2001-01-25 | 2002-08-01 | Bristol-Myers Squibb Company | Pharmaceutical forms of epothilones for oral administration |
BRPI0207961B8 (pt) | 2001-03-14 | 2021-05-25 | Bristol Myers Squibb Co | uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos. |
WO2003105828A1 (en) | 2002-06-14 | 2003-12-24 | Bristol-Myers Squibb Company | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
US7172884B2 (en) | 2002-09-23 | 2007-02-06 | Bristol-Myers Squibb Company | Methods for the preparation, isolation and purification of epothilone B, and x-ray crystal structures of epothilone B |
US7460891B2 (en) | 2002-10-21 | 2008-12-02 | Microsoft Corporation | Method and system to shut down and control computer radios |
-
2002
- 2002-02-06 RU RU2003128311/14A patent/RU2003128311A/ru not_active Application Discontinuation
- 2002-02-06 MX MXPA03007394A patent/MXPA03007394A/es unknown
- 2002-02-06 PL PL02363362A patent/PL363362A1/xx not_active Application Discontinuation
- 2002-02-06 EE EEP200300396A patent/EE200300396A/et unknown
- 2002-02-06 EP EP02714885A patent/EP1385529A4/en not_active Withdrawn
- 2002-02-06 CA CA002438610A patent/CA2438610A1/en not_active Abandoned
- 2002-02-06 KR KR10-2003-7010871A patent/KR20040025895A/ko not_active Application Discontinuation
- 2002-02-06 BR BR0207487-7A patent/BR0207487A/pt not_active Application Discontinuation
- 2002-02-06 CN CNA02805251XA patent/CN1774253A/zh active Pending
- 2002-02-06 JP JP2002565596A patent/JP2004522774A/ja active Pending
- 2002-02-06 HU HU0303175A patent/HUP0303175A2/hu unknown
- 2002-02-06 WO PCT/US2002/004255 patent/WO2002066038A1/en not_active Application Discontinuation
- 2002-02-06 IL IL15698802A patent/IL156988A0/xx unknown
- 2002-02-08 US US10/072,123 patent/US6686380B2/en not_active Ceased
-
2003
- 2003-08-07 BG BG108075A patent/BG108075A/bg unknown
- 2003-08-08 ZA ZA200306173A patent/ZA200306173B/en unknown
- 2003-08-18 IS IS6918A patent/IS6918A/is unknown
- 2003-08-19 NO NO20033684A patent/NO20033684L/no not_active Application Discontinuation
-
2006
- 2006-02-02 US US11/346,579 patent/USRE41393E1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1385529A4 (en) | 2007-05-09 |
JP2004522774A (ja) | 2004-07-29 |
BG108075A (bg) | 2005-04-30 |
NO20033684L (no) | 2003-10-13 |
BR0207487A (pt) | 2004-08-10 |
EP1385529A1 (en) | 2004-02-04 |
CN1774253A (zh) | 2006-05-17 |
KR20040025895A (ko) | 2004-03-26 |
RU2003128311A (ru) | 2005-03-10 |
US20020165258A1 (en) | 2002-11-07 |
MXPA03007394A (es) | 2003-12-04 |
IL156988A0 (en) | 2004-02-08 |
IS6918A (is) | 2003-08-18 |
US6686380B2 (en) | 2004-02-03 |
WO2002066038A1 (en) | 2002-08-29 |
PL363362A1 (en) | 2004-11-15 |
USRE41393E1 (en) | 2010-06-22 |
CA2438610A1 (en) | 2002-08-29 |
NO20033684D0 (no) | 2003-08-19 |
HUP0303175A2 (hu) | 2003-12-29 |
ZA200306173B (en) | 2004-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200300396A (et) | Epotilooni derivaatide kasutamine refraktaarsete kasvajate raviks | |
EE200300397A (et) | Epotilooni derivaadid refraktaarsete kasvajate raviks | |
EE200200673A (et) | Kinasoliini derivaadid kasvajate raviks | |
NO20013380L (no) | 2-aminobenzoksazinonderivater for behandling av fedme | |
NO20052894D0 (no) | 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte | |
NO20042140L (no) | Terapeutiske quionolonforbindelser med 5-HT anatagonistiske egenskaper | |
EE200300497A (et) | Pürasoolderivaadid HIV raviks | |
DE60223278D1 (de) | Nicotin- oder isonicotin benzothiazole derivaten | |
NO20035156D0 (no) | Fremgangsmåter for brönnbehandling | |
DK1343773T3 (da) | Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser | |
NO20033203D0 (no) | Terapeutiske heterocykliske forbindelser | |
HK1068551A1 (en) | Substituted benzimidazole compounds and their use for the treatment of cancer | |
NO20013381D0 (no) | 2-oksybenzoksazinonderivater for behandling av fedme | |
EE200200571A (et) | Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks | |
NO20040516L (no) | Kombinasjonsterapi for behandling av kreft. | |
PL373912A1 (en) | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases | |
NO20020358D0 (no) | Anvendelse av etodolac for behandling av kreft | |
EE200200511A (et) | Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks | |
EE200200577A (et) | Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks | |
NO20033341D0 (no) | Metoder for administrering av epothilone-analoger for behandling av kreft | |
NO20042476L (no) | Anvendelse av desoxypeganin for behandling av klinisk depresjon | |
NO20043113L (no) | Fremgangsmate for behandling av benforstyrrelse | |
NO20033290D0 (no) | Pyrrolderivater for behandling av cytokinformidlede sykdommer | |
NO20042542L (no) | Anvendelse av ascomycin for behandling av blefarit | |
NO20042166L (no) | Kombinasjonsterapi for behandling av sykdom |